novo nordisk eli lilly - Search News

Order byBest matchMost fresh

News

Novo Nordisk, Eli Lilly

· 33m · on MSN

Eli Lilly, Novo Nordisk latest battle in GLP-1 market war: cash-paying customers

As Eli Lilly and Novo Nordisk have been battling it out to gain market share of the growing GLP-1 weight loss market, one demographic has been seen as increasingly important: cash-pay customers. These individuals,

Continue reading

· 2h · on MSN

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Novo Nordisk, Eli Lilly, Soho House: Stocks

2d

Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines Ahead

Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...

4h

Novo Nordisk stock soar 5% today: here’s why analysts are bullish

Novo Nordisk stock gains as FDA expands Wegovy use, while Ozempic price cut aims to boost access and defend market share.

4hon MSN

Why Novo Nordisk Stock Popped Monday

Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...

3d

Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results